•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.PTC Inc. (PTC) Up 16.6% Since Last Earnings Report: Can It Continue?
PTC Therapeutics to Participate in Upcoming Investor Conferences
PTC Therapeutics Announces New Sephience™ (sepiapterin) Data Reinforcing Broad Patient Benefits Including Sustained Metabolic Control and Diet Liberalization as well as Consistent Favorable Safety Profile
PTC Therapeutics: An Acquisition Which Could Unlock Massive Potential
PTC Therapeutics Targets Fabry Gene Therapy in $111M Bankruptcy Auction Deal
PTC Therapeutics Expands Rare Disease Portfolio with 'Unique Opportunity'
PTC Advances Leadership in AI-Driven Design with Launch of Onshape FeatureScript MCP Server
PTC to Expand Rare Disease Portfolio with Acquisition of BLA-Stage ST-920 Fabry Disease Program
PTC Inc. (NASDAQ:PTC) Receives Average Recommendation of “Hold” from Brokerages
Bank of America Corp DE Sells 39,720 Shares of PTC Inc. $PTC
Is It Too Late to Buy PTC Inc (PTC) After 5.9% Rally? GF Value Says Undervalued
PTC Strengthens ALM Portfolio with New AI and Configuration Management Capabilities for Enterprise Complexity
PTC Will Participate in Upcoming Investor Conferences
PTC Launches Arena Connect to Simplify Enterprise Integrations for Manufacturers
PTC Rides AI, Cloud and Product Data Trends Across Industrial Markets
PTC's AI-Led Lifecycle Strategy Reshapes Its Long-Term Growth Outlook
Is PTC Stock Attractive After Its Sharp Pullback and Mixed Earnings?
Arrowstreet Capital Limited Partnership Cuts Position in PTC Inc. $PTC
PTC Inc. $PTC Shares Purchased by Amundi
PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results